Evidence map›Paper›PMID 36826029›Full record

ArticleCurrent issues in molecular biology2023

Effects of

Hae Lim Kim, Sung Kwon Lee, Da Eun Min, Tonking Bastola, Bo Yoon Chang, Jin Hye Bae, Dong Ryung Lee

Open access · goldAbstract read
In one paragraph

Article in Current issues in molecular biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Hae Lim KimResearch Institute, NUON Co., Ltd., Jungwon-gu, Seongnam 13201, Republic of Korea.ORCID 0000-0003-3038-1767
Sung Kwon LeeResearch Institute, NUON Co., Ltd., Jungwon-gu, Seongnam 13201, Republic of Korea.
Da Eun MinResearch Institute, NUON Co., Ltd., Jungwon-gu, Seongnam 13201, Republic of Korea.ORCID 0000-0002-6455-0090
Tonking BastolaInstitute of Pharmaceutical Research and Development, College of Pharmacy, Wonkwang University, Iksan 54538, Republic of Korea.ORCID 0000-0002-3779-7178
Bo Yoon ChangInstitute of Pharmaceutical Research and Development, College of Pharmacy, Wonkwang University, Iksan 54538, Republic of Korea.
Jin Hye BaeInstitute of Pharmaceutical Research and Development, College of Pharmacy, Wonkwang University, Iksan 54538, Republic of Korea.
Dong Ryung LeeResearch Institute, NUON Co., Ltd., Jungwon-gu, Seongnam 13201, Republic of Korea.
Wonkwang University · KR

Funding

Rural Development Administration, Republic of Korea PJ016015022022
6 · The paper itself

Abstract

Alzheimer's disease (AD) is a worldwide problem. Currently, there are no effective drugs for AD treatment.

Indexed as

anti-apoptoticanti-inflammationantioxidantAβ1–42/Tau hyperphosphorylationBrainon®cognitive dysfunctionmito/autophagySAMP8 miceScrophularia buergerianasynaptic plasticity/neurotransmitter

Identifiers

PMID36826029
PMCPMC9955813
OpenAlexW4319297002

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.